Enhanced cellulose degradation

US2016168609A1 · US · A1

Patent metadata
FieldValue
Publication numberUS-2016168609-A1
Application numberUS-201514941492-A
CountryUS
Kind codeA1
Filing dateNov 13, 2015
Priority dateApr 4, 2011
Publication dateJun 16, 2016
Grant date

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present disclosure provides compositions and methods related to the degradation of cellulose and cellulose-containing materials. CDH-heme domain polypeptides and GH61 polypeptides and related polynucleotides and compositions are provided herein. Additionally, methods related to CDH-heme domain polypeptides, GH61 polypeptides, and related polynucleotides and compositions, are provided herein

First claim

Opening claim text (preview).

1 - 18 . (canceled) 19 . A method of degrading cellulose, the method comprising contacting the cellulose with: one or more cellulases, a recombinant GH61 polypeptide; and a recombinant CDH-heme domain polypeptide comprising a cellulose binding module (CBM), wherein the contact occurs in a reaction mixture, and wherein the contact occurs for a time sufficient to yield degraded cellulose. 20 - 27 : (canceled) 28 . The method of claim 19 , wherein at least 50% of the GH61 polypeptides are bound to a copper atom. 29 . The method of claim 19 , wherein at least 90% of the GH61 polypeptides are bound to a copper atom. 30 - 31 : (canceled) 32 . The method of claim 19 , wherein the recombinant GH61 polypeptide comprises the amino acid sequence of SEQ ID NO: 24, SEQ ID NO: 26, SEQ ID NO: 28, SEQ ID NO: 30, or SEQ ID NO: 90. 33 - 37 : (canceled) 38 . The method of claim 19 , wherein the recombinant CDH-heme domain polypeptide comprises the amino acid sequence of SEQ ID NO: 32 or SEQ ID NO: 46. 39 . The method of claim 19 , wherein the CDH-heme domain comprises the amino acid sequence selected from the group consisting of SEQ ID NO: 70, SEQ ID NO: 76, SEQ ID NO: 80, and SEQ ID NO: 86, and wherein the CBM comprises the amino acid sequence of SEQ ID NO: 74 or SEQ ID NO: 84. 40 . The method of claim 19 , wherein the method further comprises having a concentration of between 0.1-500 μM copper in the reaction mixture. 41 . The method of claim 40 , wherein the concentration of copper in the reaction mixture is 1-50 μM. 42 . The method of claim 19 , wherein the recombinant GH61 polypeptide comprises an amino acid sequence having at least 80% sequence identity to the amino acid sequence of SEQ ID NO: 24, SEQ ID NO: 26, SEQ ID NO: 28, SEQ ID NO: 30, or SEQ ID NO: 90. 43 . The method of claim 19 , wherein the recombinant CDH-heme domain polypeptide comprises an amino acid sequence having at least 80% sequence identity to the amino acid sequence of SEQ ID NO: 32 or SEQ ID NO: 46. 44 . The method of claim 19 , wherein the CDH-heme domain comprises an amino acid sequence having at least 80% sequence identity to the amino acid sequence selected from the group consisting of SEQ ID NO: 70, SEQ ID NO: 76, SEQ ID NO: 80, and SEQ ID NO: 86, and wherein the CBM comprises an amino acid sequence having at least 80% sequence identity to the amino acid sequence of SEQ ID NO: 74 or SEQ ID NO: 84. 45 . The method of claim 19 , wherein the recombinant GH61 polypeptide comprises the motif H-X (4-8) -Q-X-Y. 46 . The method of claim 19 , wherein the recombinant CDH-heme domain polypeptide comprises a first domain and a second domain, wherein the first domain comprises a CDH-heme domain and the second domain comprises a CBM, and wherein the polypeptide does not contain a dehydrogenase domain. 47 . The method of claim 19 , wherein the recombinant CDH-heme domain polypeptide comprises a first domain, a second domain, and a third domain, wherein the first domain comprises a CDH-heme domain, the second domain comprises a CBM, and the third domain comprises a dehydrogenase domain.

Assignees

Inventors

Classifications

  • C12N9/0006Primary

    acting on CH-OH groups as donors (1.1) · CPC title

  • C12P19/14Primary

    produced by the action of a carbohydrase {(EC 3.2.x)}, e.g. by alpha-amylase {, e.g. by cellulase, hemicellulase} · CPC title

  • Monosaccharides (2-ketogulonic acid C12P7/60) · CPC title

  • Treatment of cellulose-containing material with microorganisms or enzymes · CPC title

  • Fusion polypeptide · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US2016168609A1 cover?
The present disclosure provides compositions and methods related to the degradation of cellulose and cellulose-containing materials. CDH-heme domain polypeptides and GH61 polypeptides and related polynucleotides and compositions are provided herein. Additionally, methods related to CDH-heme domain polypeptides, GH61 polypeptides, and related polynucleotides and compositions, are provided herein
Who is the assignee on this patent?
Univ California
What technology area does this patent fall under?
Primary CPC classification C12N9/0006. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Thu Jun 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (A1). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).